SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...

SAN DIEGO--(BUSINESS WIRE)--With Lyme disease season in full-swing across the United States and as the public continues spending increasing time outdoors during the COVID-19 pandemic, Quidel’s ...

SAN FRANCISCO - The Pac-12 Conference announced today that it has entered into an agreement with diagnostic test leader Quidel Corporation to implement up to daily testing for COVID-19 with ...

SAN DIEGO, May 26, 2022 (GLOBE NEWSWIRE) -- Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic ...

Quidel Corporation has announced an exclusive, worldwide license to the MChip microarray based influenza detection technology developed by scientists at the University of Colorado (CU) in ...

Pac-12 first college athletics conference to offer a conference-wide daily rapid-results testing regimen to limit spread of COVID-19. SAN FRANCISCO - The Pac-12 Conference announced today that it has ...

SAN DIEGO — QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion ...

Quidel plans initial release to professional and point-of-care segments with a goal of expansion to serve telemedicine and home markets Sofia Q is the latest product in Quidel’s best-selling Sofia ...

QuidelOrtho Corporation QDEL is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The ...

DUBLIN, June 29, 2023 /PRNewswire/ -- The "UAE Fertility Testing Devices Market, By Product Type (Ovulation Prediction Kits, Fertility Monitors, Male Fertility Testing Products), By Application, By ...